23 employees
Osprey Medical develops and commercializes its propriety CINCOR™ System designed for the prevention of contrast induced mephropathy.
2005
$25M
from 2 investors over 2 rounds
Osprey Medical raised $25M on August 2, 2016
Investors: Canaccord Financial and Bell Potter Securities